Viewing Study NCT03417895


Ignite Creation Date: 2025-12-24 @ 2:07 PM
Ignite Modification Date: 2026-01-15 @ 7:03 PM
Study NCT ID: NCT03417895
Status: COMPLETED
Last Update Posted: 2024-08-07
First Post: 2018-01-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small-cell Lung Cancer View
Keywords: